CautionPriadel / Camcolit
Lithium
Mood stabiliser
Ebstein's anomaly risk in T1; narrow therapeutic window in pregnancy.
Oral
First-line for
- Bipolar affective disorder maintenance (non-pregnant)
- Prevention of postpartum bipolar relapse (specialist)
Mechanism
Not fully understood — modulates IP3/DAG second messengers, GSK-3β inhibition, neuroprotection.
"Lithium loves the levels — Ebstein and thyroid"
- Ebstein's anomaly RR ~1.5–3 (absolute ~1 in 1000)
- Levels rise sharply after delivery — check weekly late T3
- Neonatal 'floppy baby', hypothyroidism, DI
Dosing
- Standard
- 400–1200 mg OD (target level 0.6–1.0 mmol/L)
- Pregnancy monitoring
- Levels every 4 weeks, then weekly from 36 weeks, then postpartum
Contraindications
- AbsoluteSevere renal impairment
- AbsoluteUntreated hypothyroidism
- CautionPregnancy — specialist perinatal psychiatry only
Side effects
- Tremor, polyuria (nephrogenic DI)
- Hypothyroidism, hyperparathyroidism
- Weight gain
- Toxicity: coarse tremor, ataxia, seizures, coma
Fetal & maternal notes
- • T1: Ebstein's anomaly and other cardiac defects — fetal echo at 18–20 wk
- • T3: monitor neonate for hypotonia, poor feeding, thyroid + renal function
- • Breastfeeding possible with close monitoring
Key interactions
NSAIDs
Avoid↑ lithium levels significantly
ACEi / ARB / diuretics
Avoid↑ lithium levels
Antipsychotics
CautionNeurotoxicity (esp. haloperidol)
Clinical pearls
- 💡 Hydration and sodium status crucial — avoid dehydration in HG or labour
- 💡 Halve dose or hold at labour onset per perinatal psychiatry plan
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.